Pelizaeus-Merzbacher disease (PMD) results from an X-linked misexpression of proteolipid protein 1 (PLP1). This leukodystrophy causes severe hypomyelination with progressive inflammation, leading to neurological dysfunctions and shortened life expectancy. While no cure exist for PMD, experimental cell-based therapy in the dysmyelinated shiverer model suggested that human oligodendrocyte progenitor cells (hOPCs) or human neural precursor cells (hNPCs) are promising candidates to treat myelinopathies. However, the fate and restorative advantages of human NPCs/OPCs in a relevant model of PMD has not yet been addressed. Using a model of Plp1 overexpression, resulting in demyelination with progressive inflammation, we compared side-by-side the therapeutic benefits of intracerebrally grafted hNPCs and hOPCs. Our findings reveal equal integration of the donor cells within presumptive white matter tracks. While the onset of exogenous remyelination was earlier in hOPCs-grafted mice than in hNPC-grafted mice, extended lifespan occurred only in hNPCsgrafted animals. This improved survival was correlated with reduced neuroinflammation (microglial and astrocytosis loads) and microglia polarization towards M2-like phenotype followed by remyelination. Thus modulation of neuroinflammation combined with myelin restoration is crucial to prevent PMD pathology progression and ensure successful rescue of PMD mice. These findings should help to design novel therapeutic strategies combining immunomodulation and stem/progenitor cell-based therapy for disorders associating hypomyelination with inflammation as observed in PMD.
disorder depends upon the nature of PLP1 mutations, which include duplication and point mutations. Changes in expression of myelin proteins are associated with progressive hypertrophic astrogliosis and massive microglial activation in animal models of PMD [1] [2] [3] and in man [4, 5] . Interestingly, microglia/macrophage activation varies with disease severity in PMD patients and PLP1 mutant mice, indicating that the inflammatory response to PLP1 gene mutations is conserved among species [5] . Complete PLP1 gene duplication (62%) [6] is the most common cause of PMD and leads to marked CNS hypomyelination. This mutation increases PLP1 gene dosage [7] primarily causing toxic PLP1 accumulation in oligodendrocyte endoplasmic reticulum [8] , leading to microglial activation and oligodendrocyte death [9] . As PLP1 is fully conserved between mouse and human and no spontaneous duplication of Plp1 exists in animal models, several transgenic mice overexpressing Plp1 were generated to decipher PMD pathohysiology [7, 10] . The transgenic Plp-tg line #66, exhibiting a 2-fold transcriptional overexpression of Plp1, is the most relevant model of PMD with Plp1 duplication [11] . Mice phenotype includes severe hypomyelination, progressive astrocytosis and microglial activation, seizures, motor and sensory deficits and a shortened lifespan [7] , as in PMD patients [5, 12] .
While there is currently no cure for PMD, transplantation of neural precursor cells (NPCs) or oligodendrocyte progenitor cells (OPCs) has emerged as a promising approach to replace affected oligodendrocytes. Indeed, successful myelination was achieved after engraftment of human NPCs [13, 14] and OPCs [15, 16] derived from fetal brain or differentiated from induced pluripotent stem cells (iPS) [17] in the immunodeficient dysmyelinated shiverer model. Extended lifespan of shiverer mice has been reported after transplantation with hOPCs [18] but not with hNPCs, suggesting that hOPCs might be the best cell candidate to treat myelin disorders such as PMD [15, 19, 20] . On the other hand, NPCs could have an advantage compared to OPCs in diseases associating demyelination and inflammation like 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w 5 PMD. Indeed, NPCs that release multiple neurotrophins and cytokines, have been shown to attenuate brain inflammation after delivery in inflammatory models of multiple sclerosis [21] [22] [23] [24] , and to decrease classically activated (M1-like) macrophages in severely contused spinal cord [25] . Although shiverer mice, due to their MBP deficiency, are an excellent model system to trace donor-derived myelin, these mice are not representative of PMD since they do not display mutations in the Plp1 gene, nor do they reflect the noxious inflammatory component of PMD [3, 5, 26] . To date the therapeutic benefits of hNPCs and/or hOPCs after transplantation in a relevant model of PMD, such as Plp1 duplication, characterized by demyelination and progressive inflammation, is still lacking. Understanding the therapeutic impact of each cell type when facing such noxious environment would foster successful translation of stem cell-based therapy from bench to clinic.
In this study, we took advantage of the Plp-tg line #66 that faithfully mimics PMD duplication. We crossed Plp-tg mice over the Rag null background (Plp-tg:Rag) to prevent rejection of the human donor cells and compared in parallel the therapeutic benefits of intracerebrally grafted hNPCs and hOPCs. We report that upon transplantation in the neonate immunodeficient Plp1 overexpressing mice, both cell types integrated equally well in the PMD environment. While each cell type functionally replaced the host deficient oligodendrocytes within the time-frame corresponding to their differentiation stage, only hNPCs rescued the severely affected PMD mice. The impressive therapeutic benefit of hNPCs was directly correlated with their ability to modulate inflammation prior to remyelination.
These data indicate that inflammatory modulation is a pre-requisite to myelin restoration to promote survival and clinical recovery of PMD mice. They also suggest promising perspectives of combining immunomodulation and stem/progenitor cell-based therapy for myelin disorders associating hypomyelination with inflammation. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Materials and Methods

Mouse line
Plp-tg mice (mouse line #66), overexpressing Plp1 genes resulted from the autosomal insertion of a transgene comprising seven copies of the wild type murine Plp1 gene [7] . To avoid cell rejection, homozygous Plp-tg mice were crossed to homozygous recombination activating gene-2 null immunodeficient mice to generate Plp-tg:Rag mice (tg66/tg66 x Rag2 -/-). Shiverer:Rag2 -/mice were used in this study to confirm the timing of myelination by the different transplanted cells. These mice were generously provided by S. Goldman's laboratory [16] .
hNPCs culture
Human foetuses were obtained after legal abortion according to the recommendations of the Agence de la Biomedecine (agreement #003187) with the written consent of the patients.
hNPCs were isolated from lateral ganglionic eminences of human foetuses (7 to 9 weeks of gestation) as previously described [13] . They were amplified in spheres in N medium (consisting of a 1:1 mixture of Dulbecco's modified Eagle's medium-F12 supplemented with 1% N2 supplement; 0.5% B27; 5 mM HEPES (all Life technologies); 20 ng/ml insulin (Eurogenetec); 6 mg/ml glucose (Sigma) supplemented with 20 ng/ml basic fibroblast growth factor and 20 ng/ml epidermal growth factor (Peprotech).
CMV-GFP transduction of hNPCs
For their traceability after transplantation, hNPCs were transduced with the cytomegalovirusgreen fluorescent protein (CMV-GFP) lentiviral vector at an MOI of 1. 
Isolation of CD11+ cell from corpus callosum of Plp-tg:Rag mice
Fifteen week old Plp-tg:Rag mice (n=4) of each group (hNPCs-grafted, hOPCs-grafted and ungrafted) were anesthetized with pentobarbital (50mg/kg) and then sacrificed by transcardiac perfusion with PBS 1X. Corpora callosa were isolated and dissociated using the "neural tissue dissociation kit (P)" (Miltenyi) in combination with the gentleMACS Dissociator. In order to significantly improve CD11b staining of the resulting single-cell suspensions, myelin debris were removed according to "myelin removal beads II" instructions (Myltenyi). Finally, CD11b+ cells were magnetically labeled with "CD11b MicroBeads" (Miltenyi) and harvested on the MACS Separator. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Primers used to quantify M1-like and M2-like gene expression of CD11b + cells, isolated from the corpora callosa of hNPCs / hOPCs-grafted and ungrafted (homozygous) Plp-tg:Rag mice, were designed according to Chhor et al., 2013 [27] .
Primary microglial culture
Primary mixed glial cell cultures were prepared from newborn C57BL/6 mouse brain. After removal of the meninges, cortices were dissociated and the resulting cell suspension was resuspended in Dulbecco's modified Eagle's medium supplemented with 10% foetal bovine serum (all Life Technologies). Microglial cells were isolated from this primary mixed glial culture on day 14 by shaking before plating at 20,000 cells / cm 2 . The following day, microglial cells were treated for 24h with IFNγ at 100 µg/mL or IL-4 at 50 µg/mL (R&D 
Electron microscopy
For phenotype characterization, ungrafted Plp-tg:Rag mice were sacrificed at 4 weeks by transcardiac perfusion with 4% paraformaldehyde/2.5% glutaraldehyde (Euromedex). Brains were cut into 70 µm-thick pieces and fixed in 2% osmium tetroxide (Sigma) overnight.
For characterization of donor-derived myelin by immuno-electron microscopy, grafted animals were perfused with 4% paraformaldehyde and 0.025% glutaraldehyde (Electron Microscopy Science). Brains were removed and cut into 70 µm slices with a vibratome VT-1000S (Leica). For GFP immunodetection, slices were incubated overnight with anti-GFP (1:400, Nacalai Tesque, 04404-84) at 4°C, followed by 3 hours incubation at room temperature with biotin-conjugated anti-rat antibody (1:100, Jackson Beckman, 112-066-062), followed with streptavidin conjugated to beta-galactosidase (1:100, Vector, A-2300). Beta galactosidase was revealed by Bluo-Gal (Sigma) incubation for 3 hours at 37°C.
Immunolabeled slices were then post-fixed with 2.5% glutaraldehyde for 2 h and 2% osmium tetroxide (Electron Microscopy Science) for 30 min. After dehydration, samples were embedded in epon. Ultra-thin sections were analyzed with a Hitachi HT7700 electron microscope. 
Behavioural assays
Global locomotor performances of grafted and ungrafted mice were evaluated using a rotarod (Letica, Barcelona, Spain) to measure coordination balance and motor control of hindlimbs.
Tests were performed at 10, 15, 20 and 33 weeks post-grafting. Mice were placed on a rotating beam. The rod was set to accelerate from 4 to 40 revolutions per minute (rpm) over 30s and then maintained a constant speed. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Quantification analysis and statistical analysis
Results
Characterization of Plp-tg:Rag mice
To prevent immune-rejection and facilitate analysis of transplanted human xenografts, Plpoverexpressing mice (line #66) were crossed with the immunodeficient strain Rag2 -/-. We first confirmed that the Rag2 -/phenotype did not alter the phenotype of the Plp-tg mice. Although myelination onsets after birth, widespread hypomyelination [7] was detected in all one month old homozygous Plp-tg:Rag brains as viewed by T2 weighted imaging ( 
Characterization of hNPCs and hOPCs
Human NPCs were isolated from lateral ganglionic eminences of three independent foetuses [13] and differentiated in vitro into hOPCs. We previously demonstrated after long-term in vitro amplification (100 days) that hNPCs conserved their immature state and their proliferative activity expressing, respectively, the neural stemness marker Nestin (98.5%) and proliferation marker Ki67 (42.6%), and only few differentiated cells expressing GFAP (5.6%), TuJ1 (2.1%), Olig2 (32.4%) and A2B5 (3.4%).. Moreover, these cells were multipotent after engraftment into the adult demyelinated nude spinal cord, and they successfully remyelinated the demyelinated adult shiverer spinal cord [13] .
To avoid heterogeneity among cell sources, hOPCs were derived from the in vitro differentiation of these hNPCs, in the presence of platelet-derived growth factor (PDGF). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 13 After three weeks, cell cultures were specifically enriched in early hOPCs by fluorescenceactivated cell sorting (FACS) using the OPC specific cell marker, CD140a/PDGFRα [15] .
Consequently, CD140a positive cell fractions were all positive for CD140a/PDGFRα. The majority expressed Ki67 (>80%) and Olig2 (>90%). Moreover they showed a typical OPC bipolar phenotype ( Fig. 2A-C) . In contrast, the CD140a negative fractions did not express To better define the CD140a + /PDGFRα + sorted cells, we compared their myelinogenic potential to hNPCs after transplantation into newborn shiverer:Rag mice. In line with previous studies [15, 16] , our results indicated faster myelinogenic capacity of hOPCs 
Grafted hNPCs improve Plp-tg:Rag mice lifespan and locomotion
We next evaluated the therapeutic outcome of hNPCs and hOPCs in the PMD model. We first assessed the effects of both cell types on survival and locomotion after bilateral cell injections 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Long-term cell survival and widespread migration is achieved equally by grafted hNPCs and hOPCs in Plp-tg:Rag mice
To decipher why hNPCs rescued Plp-tg:Rag mice in contrast to hOPCs, we first analysed survival and migratory potentials of the grafted cells. At 15 weeks p.t., both grafted cell types extensively invaded brain regions and more particularly the fimbria and the corpus callosum 16 revealed multiple branched processes ending in T shape, a typical feature of myelin-forming oligodendrocytes [13] connecting host axons (Fig. 5D ). The myelinating potential of transplanted cells was further investigated by immuno-electron microscopy at 48 weeks p.t.
BluoGal precipitates, which reveal GFP staining, were restricted to myelin structures and were exclusively present in areas containing GFP + cells prior to embedding. Therefore, detection of BluoGal precipitates by electron microscopy within myelin wrapping of host axons validated that myelin was donor derived (Fig. 5E ). Higher magnification indicated that the donor-derived myelin was normally compacted. Finally, immunostaining for the paranodal protein Caspr and nodal Neurofascin revealed a higher density of nodes of Ranvier in areas of the corpus callosum containing GFP + cells compared to areas lacking GFP + cells or to ungrafted mice (Fig. 5F) . Moreover, co-labeling for GFP and Caspr confirmed the donor origin of the paranodal structures (Fig. 5G) . These data indicate nodal reconstitution by the gratfed cells and highlight the functionality of the donor-derived myelin.
Only grafted hNPCs down-regulate inflammation in Plp-tg:Rag mice
Despite their potential for efficient integration and myelination, hOPCs failed to improve the survival of Plp-tg:Rag mice. We therefore asked whether these two grafted cell populations might differentially modulate their host environment and in particular the inflammatory burden of Plp-tg:Rag mice. Indeed, PLP1 overexpression leads to increased astrocytosis and massive microglial activation, both associated with aggravated clinical symptoms. We 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Discussion
PLP1 overexpression exerts a toxic gain-of-function resulting in oligodendrocyte death.
Current endogenous repair strategies aim to minimize pathological effects of mutations using micro RNA to reduce Plp1 mRNA levels [28] , or cholesterol treatment [29] . However, cell substitution may be another promising alternative therapy for PMD.
Proof of principle for cell-based therapy for PMD was provided by transplanting rodent CNS tissue fragments in jimpy mice [30] , a PMD model of Plp1 gene point-mutation, and was further confirmed by grafting purified populations of rodent glial precursor cells in myelindeficient (md) rats [31] or shaking pups [32] . Although these studies demonstrated that nonaffected rodent precursor cells survived and differentiated normally into oligodendrocytes in the PMD environment, the benefit of rodent NPCs or human NPCs/OPCs engraftment in these models has not been investigated. Moreover, rational progress with cell-therapy requires comparison of different cell types (NPCs versus OPCs) in the same experimental paradigm.
Finally, in view of the obvious differences in biology existing between human and rodent cells, the efficacy of human cells in a relevant model of PMD has not been demonstrated but is required for appropriate clinical translation of cell therapy for PMD. In this study, we addressed whether hOPCs or hNPCs are better candidates for PMD cell-based therapy, by comparing these two populations in parallel after engraftment into the newborn brain of a mouse model of severe PMD.
Plp-tg mice were backcrossed with Rag2 -/littermates to prevent human cell rejection. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Several studies highlighted that transplantation of hOPCs, derived from foetal brain or from iPS, into immunodeficient shiverer:Rag mouse brain induced widespread myelination and extended lifespan of their host [17, 18] . Surprisingly, this was not the case when hOPCs were grafted into Plp-tg:Rag mice. In spite of the presence of extensive exogenous myelination, hOPCs-grafted mice died as prematurely as ungrafted mice (20 weeks). The failure of hOPCs to promote Plp-tg:Rag survival was not due to any potential intrinsic defect of the grafted hOPCs population. Indeed, these hNPCs-derived hOPCs were bonified hOPCs expressing OPCs markers such as PDGFRα and Olig2, as validated at the protein and transcriptional levels. Second, after engraftment into immunodeficient shiverer:Rag mice, grafted hOPCs differentiated successfully into myelin-forming cells and improved host survival, from 23 to 30 weeks (Fig. 2J ) as previously reported [17] . Additionally, their failure to improve Plp- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 restoration. Moreover, the difference in survival between these two models highlights the limits of the shiverer model [26] and the necessity to use more relevant disease models, such
Although previous studies have demonstrated the involvement of T-lymphocytes in myelin
as Plp-tg:Rag mice, to develop efficient cell therapy for PMD.
Unlike in shiverer mice [13] , hNPCs transplanted into Plp-tg:Rag animals differentiated predominantly into oligodendrocytes but to a minor extent into astrocytes or neurons, suggesting that disease-specific environments affect differentially the fate of exogenous cells.
Therefore, it seems that therapeutic strategies using hOPCs with astrocytes or neurons cannot be efficient in PMD. It also highlights that the major difference in the respective therapeutic benefits between hNPCs and hOPCs results more from mechanisms such as modulation of inflammation rather than the myelination capacities of the two populations. Although hNPCs 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 22 Deciphering how hNPCs mediate the transition from M1-like to M2-like phenotype in Plptg:Rag mice could lead to the identification of therapeutic molecules and further improve PMD cell therapy [38] . Indeed, a strategy combining pharmacological immunomodulation to improve recipient survival and fast and efficient myelin replacement via cell therapy to prevent axon dysfunction would appear as an optimal therapeutic treatment for PMD and possibly other inflammatory demyelinating disorders. Indeed, although this study highlights the benefit of hNPCs transplantation in a severe PMD model, the optimal strategy could be to accelerate the generation of myelin to protect axons using hOPCs in combination with the use of immunomodulatory drugs to reduce the deleterious effect of inflammation. One could question the relevance of our data on microglia phenotype in PMD. Indeed, very few histopathological studies reported inflammation in PMD and none of them described microglial polarization. Although, recent data indicated microglial activation in a variety of PMD patients, including those affected with PLP1 duplication [5] , histopathological data are insufficient to infer whether inflammation precedes or results from demyelination. In the latter case, it could aggravate PMD physiopathology. Interestingly and even more relevant to the human disease is the effect of hNPCs on astrocytosis which is commonly described in PMD [39] . As astrocytes and microglia may be activated by each other [40] [41] [42] , it remains plausible that the observed effects on microglia are mediated via astrocytes or vice-versa.
Conclusion
In summary, we provide the first evidence that immunomodulation, myelin repair and clinical improvement can be successfully achieved by hNPCs cell therapy in a model of severe PMD.
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